Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof
The present application relates to compounds of Formula (I) or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disord...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Wilson, Brian Watson, Iain Subramanian, Pandiaraju Isaac, Methvin Poda, Gennady Uehling, David Al-awar, Rima Mamai, Ahmed Chau, Anh My |
| description | The present application relates to compounds of Formula (I) or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disorders or conditions that are treatable by inhibiting interactions with BCL6 BTB, such as cancer. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11242351B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11242351B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11242351B23</originalsourceid><addsrcrecordid>eNqNy7ENwjAQQFE3FAjY4RgghR1gAEcgCjqMRBcZ56ycFO4s2xRsD0gZgOo1_y_V3WUK7zBRAOKRHlQlF5AIdUSw3eUA1lkY5OmJIWWpSNzMfo-K2YdKwuB5gFfB8hszSlyrRfRTwc3sSm1PR9edG0zSY0k-IGPtb1etzc60e21N-0_zATmAObY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof</title><source>esp@cenet</source><creator>Wilson, Brian ; Watson, Iain ; Subramanian, Pandiaraju ; Isaac, Methvin ; Poda, Gennady ; Uehling, David ; Al-awar, Rima ; Mamai, Ahmed ; Chau, Anh My</creator><creatorcontrib>Wilson, Brian ; Watson, Iain ; Subramanian, Pandiaraju ; Isaac, Methvin ; Poda, Gennady ; Uehling, David ; Al-awar, Rima ; Mamai, Ahmed ; Chau, Anh My</creatorcontrib><description>The present application relates to compounds of Formula (I) or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disorders or conditions that are treatable by inhibiting interactions with BCL6 BTB, such as cancer.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220208&DB=EPODOC&CC=US&NR=11242351B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220208&DB=EPODOC&CC=US&NR=11242351B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Wilson, Brian</creatorcontrib><creatorcontrib>Watson, Iain</creatorcontrib><creatorcontrib>Subramanian, Pandiaraju</creatorcontrib><creatorcontrib>Isaac, Methvin</creatorcontrib><creatorcontrib>Poda, Gennady</creatorcontrib><creatorcontrib>Uehling, David</creatorcontrib><creatorcontrib>Al-awar, Rima</creatorcontrib><creatorcontrib>Mamai, Ahmed</creatorcontrib><creatorcontrib>Chau, Anh My</creatorcontrib><title>Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof</title><description>The present application relates to compounds of Formula (I) or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disorders or conditions that are treatable by inhibiting interactions with BCL6 BTB, such as cancer.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNy7ENwjAQQFE3FAjY4RgghR1gAEcgCjqMRBcZ56ycFO4s2xRsD0gZgOo1_y_V3WUK7zBRAOKRHlQlF5AIdUSw3eUA1lkY5OmJIWWpSNzMfo-K2YdKwuB5gFfB8hszSlyrRfRTwc3sSm1PR9edG0zSY0k-IGPtb1etzc60e21N-0_zATmAObY</recordid><startdate>20220208</startdate><enddate>20220208</enddate><creator>Wilson, Brian</creator><creator>Watson, Iain</creator><creator>Subramanian, Pandiaraju</creator><creator>Isaac, Methvin</creator><creator>Poda, Gennady</creator><creator>Uehling, David</creator><creator>Al-awar, Rima</creator><creator>Mamai, Ahmed</creator><creator>Chau, Anh My</creator><scope>EVB</scope></search><sort><creationdate>20220208</creationdate><title>Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof</title><author>Wilson, Brian ; Watson, Iain ; Subramanian, Pandiaraju ; Isaac, Methvin ; Poda, Gennady ; Uehling, David ; Al-awar, Rima ; Mamai, Ahmed ; Chau, Anh My</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11242351B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Wilson, Brian</creatorcontrib><creatorcontrib>Watson, Iain</creatorcontrib><creatorcontrib>Subramanian, Pandiaraju</creatorcontrib><creatorcontrib>Isaac, Methvin</creatorcontrib><creatorcontrib>Poda, Gennady</creatorcontrib><creatorcontrib>Uehling, David</creatorcontrib><creatorcontrib>Al-awar, Rima</creatorcontrib><creatorcontrib>Mamai, Ahmed</creatorcontrib><creatorcontrib>Chau, Anh My</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Wilson, Brian</au><au>Watson, Iain</au><au>Subramanian, Pandiaraju</au><au>Isaac, Methvin</au><au>Poda, Gennady</au><au>Uehling, David</au><au>Al-awar, Rima</au><au>Mamai, Ahmed</au><au>Chau, Anh My</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof</title><date>2022-02-08</date><risdate>2022</risdate><abstract>The present application relates to compounds of Formula (I) or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disorders or conditions that are treatable by inhibiting interactions with BCL6 BTB, such as cancer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US11242351B2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T21%3A20%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Wilson,%20Brian&rft.date=2022-02-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11242351B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |